Fraunhofer at MEDICA and COMPAMED 2023
"Research News": Automated, cost-effective production of mRNA vaccines as well as cell and gene therapeutics
mRNA-based vaccines and gene/cell therapeutics open up new possibilities for medical practitioners in the fight against cancer and infectious or hereditary diseases. However, manufacturing these innovative pharmaceuticals is an expensive and time-consuming process. The Fraunhofer RNAuto lighthouse project is aiming to use automated production technologies to facilitate cost-effective, high-volume production of mRNA-based drugs and medicines for personalized therapies which can then be made available at an affordable price. From November 13 to 16, researchers from the Fraunhofer-Gesellschaft will, for the first time, present a screening system demonstrator for the automated encapsulation of mRNA in nanotransporters at COMPAMED in Düsseldorf (Hall 8a, Booth G10).